糖尿病对肺癌患者代谢网络的影响:基于动态全身PET/CT成像的分析
本研究利用全身动态PET/CT成像构建代谢网络分析框架,比较20例合并糖尿病的肺癌患者与20例不合并糖尿病的肺癌患者的代谢网络差异;结果在边水平和器官水平均成功捕获糖尿病组偏离非糖尿病组,提示该框架可用于揭示糖尿病对肺癌代谢的系统性影响。
要点
- 在边水平,糖尿病组与非糖尿病组在病灶-左心室连接上差异有统计学意义(P < 0.05)。
- 病灶-左心室Z-score绝对值(ZCC)与糖尿病病程呈正相关(R = 0.680,P < 0.001)。
- 在器官水平,糖尿病组与非糖尿病组在肾脏、脑和腹部脂肪上差异有统计学意义(P < 0.05)。
核心结论
- 本研究证明了构建代谢网络以揭示合并糖尿病的肺癌患者复杂改变的可行性。
- 研究结果有助于理解糖尿病对肺癌代谢的系统性影响,并强调个性化代谢网络分析对理解并存疾病影响的重要性。
研究设计与样本
- 研究纳入20例合并糖尿病的肺癌患者(糖尿病组)和20例不合并糖尿病的肺癌患者(非糖尿病组),采用全身动态PET/CT成像进行代谢网络分析。
- 以三阶多项式拟合的残差作为Pearson相关性的指标,构建代谢网络分析框架。
主要发现
- 该框架在边水平和器官水平均成功捕获糖尿病组偏离非糖尿病组。
- 在边水平,糖尿病组与非糖尿病组在病灶-左心室连接上差异有统计学意义(P < 0.05)。
- 病灶-左心室Z-score绝对值(ZCC)与糖尿病病程呈正相关(R = 0.680,P < 0.001)。
- 在器官水平,糖尿病组与非糖尿病组在肾脏、脑和腹部脂肪上差异有统计学意义(P < 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The intricate interplay between organs can give rise to a multitude of physiological conditions. Disruptions such as inflammation or tissue damage can precipitate the development of chronic diseases such as tumors or diabetes mellitus (DM). While both lung cancer and DM are the consequences of disruptions in homeostasis, the relationship between them is intricate. This study sought to investigate the potential influence of DM on lung cancer by employing total-body dynamic PET imaging. METHODS: The present study proposes a framework for metabolic network analysis using total-body dynamic PET imaging of 20 lung cancer patients with DM (DM group) and 20 lung cancer patients without DM (Non-DM group), with the residuals of a third-order polynomial fit serving as an indicator of Pearson correlation. RESULTS: The framework successfully captured the deviation of the DM group from the Non-DM group at both the edge and organ levels. At the edge level, there was a significant difference in the lesion- left ventricle (LV) between the DM and Non-DM groups (P < 0.05). Furthermore, we discovered a positive correlation between the absolute value of Z-score (ZCC) of lesion - LV and the duration of DM (R = 0.680, P < 0.001). At the organ level, there was a significant difference in the kidney, brain, and abdominal fat between the DM and Non-DM groups (P < 0.05). CONCLUSION: This study demonstrated the feasibility of constructing metabolic networks to uncover complex alterations in lung cancer patients with DM. The findings contribute to understanding the systemic effects of DM on lung cancer metabolism and highlight the importance of personalized metabolic network analysis to comprehend the implications of concurrent diseases.
引用
- Sun L, Wu Y, Sun T, et al. Influence of diabetes mellitus on metabolic networks in lung cancer patients: an analysis using dynamic total-body PET/CT imaging. Eur J Nucl Med Mol Imaging. 2025. PMID: 39831968. doi:10.1007/s00259-025-07081-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。